These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25448228)

  • 21. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells.
    Čitar M; Hacin B; Tompa G; Štempelj M; Rogelj I; Dolinšek J; Narat M; Matijašić BB
    Benef Microbes; 2015; 6(3):325-36. PubMed ID: 25391349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tackling probiotic and gut microbiota functionality through proteomics.
    Ruiz L; Hidalgo C; Blanco-Míguez A; Lourenço A; Sánchez B; Margolles A
    J Proteomics; 2016 Sep; 147():28-39. PubMed ID: 27003613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
    Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L
    Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response.
    Corr SC; Gahan CG; Hill C
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):380-8. PubMed ID: 17537177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.
    Giardina S; Scilironi C; Michelotti A; Samuele A; Borella F; Daglia M; Marzatico F
    J Food Sci; 2014 Mar; 79(3):M384-90. PubMed ID: 24471378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between the microbiota and the intestinal mucosa.
    Schiffrin EJ; Blum S
    Eur J Clin Nutr; 2002 Aug; 56 Suppl 3():S60-4. PubMed ID: 12142966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.
    O'Shea EF; Cotter PD; Stanton C; Ross RP; Hill C
    Int J Food Microbiol; 2012 Jan; 152(3):189-205. PubMed ID: 21742394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotic and other functional microbes: from markets to mechanisms.
    Saxelin M; Tynkkynen S; Mattila-Sandholm T; de Vos WM
    Curr Opin Biotechnol; 2005 Apr; 16(2):204-11. PubMed ID: 15831388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998.
    de Roos NM; Katan MB
    Am J Clin Nutr; 2000 Feb; 71(2):405-11. PubMed ID: 10648252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prebiotic carbohydrates on growth, bile survival and cholesterol uptake abilities of dairy-related bacteria.
    Ziar H; Gérard P; Riazi A
    J Sci Food Agric; 2014 Apr; 94(6):1184-90. PubMed ID: 24037813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics as functional food in the treatment of diarrhea.
    Yan F; Polk DB
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):717-21. PubMed ID: 17053425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model.
    Tsilingiri K; Barbosa T; Penna G; Caprioli F; Sonzogni A; Viale G; Rescigno M
    Gut; 2012 Jul; 61(7):1007-15. PubMed ID: 22301383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotic Species in the Modulation of Gut Microbiota: An Overview.
    Azad MAK; Sarker M; Li T; Yin J
    Biomed Res Int; 2018; 2018():9478630. PubMed ID: 29854813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotic roles of Lactobacillus sp. in swine: insights from gut microbiota.
    Valeriano VD; Balolong MP; Kang DK
    J Appl Microbiol; 2017 Mar; 122(3):554-567. PubMed ID: 27914202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.
    Hampe CS; Roth CL
    Endocrine; 2017 Nov; 58(2):207-227. PubMed ID: 29052181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prebiotics as gut microflora management tools.
    Gibson GR
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S75-9. PubMed ID: 18542038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.